Litcius/Paper detail

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation

Yongwhan Lim, Min Chul Kim, Kye Hun Kim, In Seok Jeong, Yong Soo Cho, Yoo Duk Choi, Jong Eun Lee

2021Frontiers in Cardiovascular Medicine28 citationsDOIOpen Access PDF

Abstract

Recently, myocarditis following messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination has become an important social issue worldwide. According to the reports so far, myocarditis related to mRNA COVID-19 vaccination is rare and usually associated with a benign clinical course without intensive care or any sequelae of fulminant myocarditis. Here, we report a case of acute fulminant myocarditis and cardiogenic shock after the mRNA COVID-19 vaccination, requiring extracorporeal cardiopulmonary resuscitation. Clinicians should keep in mind the possibility of progression to fulminant myocarditis in patients who presented with suggestive symptoms or signs of myocarditis after the COVID-19 vaccination.

Topics & Concepts

MyocarditisFulminantMedicineCardiogenic shockVaccinationCardiopulmonary resuscitationShock (circulatory)ResuscitationImmunologyCardiologyIntensive care medicineInternal medicineAnesthesiaMyocardial infarctionViral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation | Litcius